Challenging Case Studies are presented by trainees or technologists. They will discuss the case's clinical history, molecular analysis, interesting features, and the proposed diagnosis. Other molecular testing methods, if applicable, will be included in the presentation, including biopsies, gross/microscopic pathology, immunohistochemistry/flow cytometry, and cytogenetic findings.
Molecular Characterization of Aspergillus Fumigatus by Next-generation Sequencing in Neonates
Diagnosed with Invasive Fungal Dermatitis at a Tertiary Care Hospital – Florida, 2019
Eun a Kim, MSc, IDbyDNA, Draper, UT, USA
SARS-CoV-2 and Cytomegalovirus Co-infection in Patients Over 45: A Case Series
Debbie Rigney Walley, MD, Houston Methodist Hospital, Houston, TX, USA
Disseminated Histoplasmosis with Concomitant Mycobacterium Haemophilum and Anncaliia Algerae
Myositis in a Polymyositis Patient: A Diagnostic Approach
William Webster, DO, University of South Carolina School of Medicine-Prisma Health, Columbia, SC, USA
Papillary Thyroid Carcinoma with Hashimoto Thyroiditis: Detecting the Driver Signal in the Inflammatory
Noise
Adam Fisch, MD, PhD, Massachusetts General Hospital, Boston, MA, USA
Next Generation Sequencing Catches a Cytopathology Pitfall
Matthew Gayhart, MD, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Objectives:
- Describe the context of a challenging clinical case.
- Discuss the molecular pathology techniques used in the diagnosis of the case.
- Propose a final diagnosis based upon findings and diagnostic evidence
Recording Date: November 16, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.00 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
